TopFunds

Agilent Technologies

NYSE: A

Stock price

168.17 USD

(+10.3%) 5 years

Life Sciences Tools & ServicesMedical - Diagnostics & Research

Financial Performance

Share

5Y price score: 13

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 270.6%

DATE RANGE:

%

ㅤ

  • Earnings per share

  • Free cash flow per share

  • Stock price

Time scale:

By default your notes are visible only to you.

108.3

52-week range

177.0

168.17

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

3 %

Dividend Yield TTM

0.6 %

Market cap $

$ 47,497

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

33.1

Price / Book TTM

6.4

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

10.5

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

20.1 %

13.2 %

270.6 %

Free cash flow per share growth

70.7 %

57.8 %

11 %

Earnings per share growth

8.5 %

98.7 %

280.8 %

Founded: 1,999

Employees: 17,900

Business Summary:Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Q&A

SEARCH
Get answers on financials, industry, fundamentals or other questions.

Contribute

By providing well-researched and detailed answer you increase your chance of becoming Top Contributor. TopFunds is free for all top contributors. Learn more

VIEW ALL Q&A

Contribute or ask questions about business following TopFunds community guidelines

Fair Value Reference Estimate

Latest Earnings Call Takeaways

2026 Q3 (Aug 26, 2026)

1) Strong Financial Performance
- Agilent reported Q3 2026 revenue of $1.88 billion, reflecting a 7.3% core growth, exceeding guidance by 140 basis points.
- Operating margin was 27.2% (excluding tariff refunds), up 80 basis points from guidance, while including refunds, it reached 28.3%.
- Earnings per share (EPS) was $1.56 (excluding refunds), a 14% YoY increase, surpassing guidance of $1.48 to $1.50. Including refunds, EPS was $1.62.

2) Growth Drivers and Market Dynamics
- Pharma segment grew 12%, driven by strong funding from large customers and a rebound in small and mid-cap biotech spending.
- Advanced Therapeutics Division saw nearly 30% growth, indicating robust demand and successful capacity expansion.
- China showed notable growth at 9%, driven by strong commercial execution and demand in pharma and food sectors, exceeding previous flat expectations.

3) Operational Excellence and Ignite Impact
- The Ignite Operating System has enhanced operational efficiency, contributing to improved margins and execution discipline.
- Strategic pricing initiatives added approximately 200 basis points to revenue growth, significantly mitigating inflationary pressures.
- The company is seeing strong momentum in instrument sales, with a book-to-bill ratio above 1 for the tenth consecutive quarter, supporting future demand.

4) Product Innovations and Future Outlook
- Recent product launches, including the 9500 Triple Quad ICP-MS and new GC systems, are performing well, with strong customer feedback and demand.
- The company anticipates continued growth in the CDMO business, with Train C expected to come online in spring 2027, supporting future revenue.
- For FY 2026, Agilent expects revenue growth of 5.8% to 6%, with EPS guidance raised to $6.18 to $6.21, reflecting strong operational leverage and market conditions.

5) Challenges and Market Considerations
- Despite strong performance, Europe showed low single-digit growth, attributed to tough year-over-year comparisons.
- The company is navigating rising material costs and geopolitical dynamics, particularly in the semiconductor and energy sectors.
- Further details on the impact of reshoring dynamics and specific order sizes were not fully disclosed, indicating potential areas for future clarification.

Bottom line: Agilent's Q3 results reflect strong operational execution and market demand, positioning the company for sustained growth amid improving end markets and strategic initiatives. Shareholders can expect continued momentum into FY 2027, supported by robust product innovations and operational efficiencies.

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Agilent Technologies — Financial Overview, Stock Price, Market Cap

Agilent Technologies is a company. Founded in 1999. As of October 9, 2026, the company's market capitalization is $47496589440 with a current stock price of $168.17.